• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性阻塞性肺疾病与心血管疾病:全身炎症的作用]

[Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation].

作者信息

Rossi Francesca Flavia, Pedone Claudio, Antonelli Incalzi Raffaele

机构信息

Università Campus Biomedico Area di geriatria Via Alvaro del Portillo 21 00128 Roma.

出版信息

Recenti Prog Med. 2011 Mar;102(3):109-13. doi: 10.1701/608.7066.

DOI:10.1701/608.7066
PMID:21572482
Abstract

Chronic obstructive pulmonary disease (COPD) is the only chronic disease whose prevalence is increasing. It is the third cause of death wordwide, and it is projected to became the third in about ten years. COPD is strongly associated with cardiovascular diseases: this association is in part explained by risk factors in common (especially smoking), but in the latest years the hypothesis that COPD may cause a systemic inflammatory state, that in turn causes the increased risk of cardiovascular diseases in these patients, is taking over. The aim of this paper is to review the available evidence about the association of COPD with systemic inflammation, and how this is linked with development of cardiovascular diseases.

摘要

慢性阻塞性肺疾病(COPD)是唯一一种患病率正在上升的慢性疾病。它是全球第三大致死原因,预计在大约十年内将成为第三大死因。COPD与心血管疾病密切相关:这种关联部分是由共同的危险因素(尤其是吸烟)解释的,但近年来,COPD可能导致全身炎症状态,进而导致这些患者心血管疾病风险增加的假说正在占据主导地位。本文的目的是综述关于COPD与全身炎症关联的现有证据,以及这与心血管疾病发展的联系。

相似文献

1
[Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation].[慢性阻塞性肺疾病与心血管疾病:全身炎症的作用]
Recenti Prog Med. 2011 Mar;102(3):109-13. doi: 10.1701/608.7066.
2
[Chronic obstructive pulmonary disease and cardiovascular system].[慢性阻塞性肺疾病与心血管系统]
Tuberk Toraks. 2008;56(4):464-71.
3
Systemic inflammation and mortality in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的全身炎症与死亡率
Can J Physiol Pharmacol. 2007 Jan;85(1):141-7. doi: 10.1139/y06-093.
4
[Chronic obstructive pulmonary disease and cardiovascular disease].[慢性阻塞性肺疾病与心血管疾病]
Arch Bronconeumol. 2010;46 Suppl 3:18-22. doi: 10.1016/S0300-2896(10)70022-3. Epub 2010 Jun 20.
5
Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.慢性阻塞性肺疾病:心血管疾病的一种新危险因素。
Can J Physiol Pharmacol. 2005 Jan;83(1):8-13. doi: 10.1139/y04-116.
6
COPD and co-morbidities, with special emphasis on cardiovascular conditions.慢性阻塞性肺疾病及合并症,特别关注心血管疾病。
Clin Respir J. 2008 Oct;2 Suppl 1:59-63. doi: 10.1111/j.1752-699X.2008.00085.x.
7
Systemic consequences of COPD.慢性阻塞性肺疾病的全身影响
Ther Adv Respir Dis. 2007 Oct;1(1):47-59. doi: 10.1177/1753465807082374.
8
[COPD and systemic inflammation. A link for comorbidity].[慢性阻塞性肺疾病与全身炎症。共病的一个关联因素]
Arch Bronconeumol. 2009;45 Suppl 4:14-7. doi: 10.1016/S0300-2896(09)72858-3.
9
Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.癌症和心血管疾病对慢性阻塞性肺疾病的影响。
Curr Opin Pulm Med. 2008 Mar;14(2):115-21. doi: 10.1097/MCP.0b013e3282f45ffb.
10
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.慢性阻塞性肺疾病作为一种具有全身影响的肺部疾病——临床影响、机制及早期干预潜力
COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531.

引用本文的文献

1
Relationship between FEV1 and Cardiovascular Risk Factors in General Population without Airflow Limitation.无气流受限的普通人群中第一秒用力呼气容积(FEV1)与心血管危险因素的关系。
Can Respir J. 2016;2016:8319849. doi: 10.1155/2016/8319849. Epub 2016 Nov 28.